126 related articles for article (PubMed ID: 38126094)
21. Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity.
Johnson AL; Zinser GM; Waltz SE
Oncotarget; 2015 Jun; 6(18):16304-20. PubMed ID: 26008979
[TBL] [Abstract][Full Text] [Related]
22. Progranulin and beta-catenin in psoriasis: An immunohistochemical study.
Farag AGA; Shoaib MA; Samaka RM; Abdou AG; Mandour MM; Ibrahim RAL
J Cosmet Dermatol; 2019 Dec; 18(6):2019-2026. PubMed ID: 31091001
[TBL] [Abstract][Full Text] [Related]
23. SphK1 inhibitor SKI II inhibits the proliferation of human hepatoma HepG2 cells via the Wnt5A/β-catenin signaling pathway.
Liu H; Zhang CX; Ma Y; He HW; Wang JP; Shao RG
Life Sci; 2016 Apr; 151():23-29. PubMed ID: 26944438
[TBL] [Abstract][Full Text] [Related]
24. Wnt5a and Wnt11 inhibit the canonical Wnt pathway and promote cardiac progenitor development via the Caspase-dependent degradation of AKT.
Bisson JA; Mills B; Paul Helt JC; Zwaka TP; Cohen ED
Dev Biol; 2015 Feb; 398(1):80-96. PubMed ID: 25482987
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D Receptor Expression in Chronic Plaque Psoriasis Before and After Narrowband Ultraviolet B Phototherapy.
Elgarhy LH; Eltatawy RA; Rizk O; Ismail M
J Cutan Aesthet Surg; 2023; 16(2):128-133. PubMed ID: 37554687
[TBL] [Abstract][Full Text] [Related]
26. Beta-catenin non-canonical pathway: A potential target for inflammatory and hyperproliferative state via expression of transglutaminase 2 in psoriatic skin keratinocyte.
Gupta G; Singh Y; Tiwari J; Raizaday A; Alharbi KS; Al-Abbasi FA; Kazmi I; Satija S; Tambuwala MM; Devkota HP; Krishnan A; Chellappan DK; Dua K
Dermatol Ther; 2020 Nov; 33(6):e14209. PubMed ID: 32816372
[TBL] [Abstract][Full Text] [Related]
27. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context.
Mikels AJ; Nusse R
PLoS Biol; 2006 Apr; 4(4):e115. PubMed ID: 16602827
[TBL] [Abstract][Full Text] [Related]
28. Toll-like receptors and antimicrobial peptides expressions of psoriasis: correlation with serum vitamin D level.
Kim SK; Park S; Lee ES
J Korean Med Sci; 2010 Oct; 25(10):1506-12. PubMed ID: 20890434
[TBL] [Abstract][Full Text] [Related]
29. Vitamin D receptor knockdown attenuates the antiproliferative, pro‑apoptotic and anti‑invasive effect of vitamin D by activating the Wnt/β‑catenin signaling pathway in papillary thyroid cancer.
Pang R; Xu Y; Hu X; Liu B; Yu J
Mol Med Rep; 2020 Nov; 22(5):4135-4142. PubMed ID: 33000217
[TBL] [Abstract][Full Text] [Related]
30. 1,25-Dihydroxyvitamin D3 Prevents Epithelial-Mesenchymal Transition of HMrSV5 Human Peritoneal Mesothelial Cells by Inhibiting Histone Deacetylase 3 (HDAC3) and Increasing Vitamin D Receptor (VDR) Expression Through the Wnt/β-Catenin Signaling Pathway.
Liu KH; Fu J; Zhou N; Yin W; Yang YY; Ouyang SX; Liang YM
Med Sci Monit; 2019 Aug; 25():5892-5902. PubMed ID: 31391414
[TBL] [Abstract][Full Text] [Related]
31. Noncanonical Wnt5a enhances Wnt/β-catenin signaling during osteoblastogenesis.
Okamoto M; Udagawa N; Uehara S; Maeda K; Yamashita T; Nakamichi Y; Kato H; Saito N; Minami Y; Takahashi N; Kobayashi Y
Sci Rep; 2014 Mar; 4():4493. PubMed ID: 24670389
[TBL] [Abstract][Full Text] [Related]
32. Reciprocal role of vitamin D receptor on β-catenin regulated keratinocyte proliferation and differentiation.
Hu L; Bikle DD; Oda Y
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():237-41. PubMed ID: 24239508
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of Wnt signaling pathway in keloid pathogenesis.
Igota S; Tosa M; Murakami M; Egawa S; Shimizu H; Hyakusoku H; Ghazizadeh M
Int J Med Sci; 2013; 10(4):344-54. PubMed ID: 23471552
[TBL] [Abstract][Full Text] [Related]
34. Distinct roles and differential expression levels of Wnt5a mRNA isoforms in colorectal cancer cells.
Huang TC; Lee PT; Wu MH; Huang CC; Ko CY; Lee YC; Lin DY; Cheng YW; Lee KH
PLoS One; 2017; 12(8):e0181034. PubMed ID: 28859077
[TBL] [Abstract][Full Text] [Related]
35. Vitamin D receptor is a novel transcriptional regulator for Axin1.
Jin D; Zhang YG; Wu S; Lu R; Lin Z; Zheng Y; Chen H; Cs-Szabo G; Sun J
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):430-437. PubMed ID: 27601169
[TBL] [Abstract][Full Text] [Related]
36. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK
Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266
[TBL] [Abstract][Full Text] [Related]
37. Higher expression of WNT5A protein in oral squamous cell carcinoma compared with dysplasia and oral mucosa with a normal appearance.
Prgomet Z; Andersson T; Lindberg P
Eur J Oral Sci; 2017 Aug; 125(4):237-246. PubMed ID: 28603941
[TBL] [Abstract][Full Text] [Related]
38. β-Catenin-independent noncanonical Wnt pathway might be induced in gastric cancers.
Gencer S; Şen G; Doğusoy G; Bellı AK; Paksoy M; Yazicioğlu MB
Turk J Gastroenterol; 2010 Sep; 21(3):224-30. PubMed ID: 20931424
[TBL] [Abstract][Full Text] [Related]
39. Wnt5a signaling controls cytokinesis by correctly positioning ESCRT-III at the midbody.
Fumoto K; Kikuchi K; Gon H; Kikuchi A
J Cell Sci; 2012 Oct; 125(Pt 20):4822-32. PubMed ID: 22825874
[TBL] [Abstract][Full Text] [Related]
40. Canonical and non-canonical Wnt signaling are simultaneously activated by Wnts in colon cancer cells.
Flores-Hernández E; Velázquez DM; Castañeda-Patlán MC; Fuentes-García G; Fonseca-Camarillo G; Yamamoto-Furusho JK; Romero-Avila MT; García-Sáinz JA; Robles-Flores M
Cell Signal; 2020 Aug; 72():109636. PubMed ID: 32283254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
